Literature DB >> 16425184

PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.

Petra W van Duijn1, Jan Trapman.   

Abstract

BACKGROUND: We compared the involvement of PI3K/PTEN/Akt signaling in the regulation of the cell-cycle regulator p27(kip1) and investigated the mechanism of PI3K/PTEN/Akt modulation of p27(kip1) in the prostate cancer cell lines LNCaP, PC346, PC3, and DU145.
METHODS: PI3K/PTEN/Akt signaling was manipulated by wortmannin or specific siRNA. The effects on PI3K/Akt downstream effectors and p27(kip1) expression were monitored on RNA and protein levels.
RESULTS: PI3K/Akt inhibition in LNCaP and PC346 cells hardly affected p27(kip1) expression. As shown in LNCaP cells, p27(kip1) expression inversely correlated with Skp2 expression, but Skp2 was not regulated by Akt. Blocking PI3K/Akt signaling in PC3 cells resulted in decreased Skp2 protein expression and increased p27(kip1). Downregulation of PTEN in DU145 cells also showed PTEN/Akt-dependent regulation of Skp2 and p27(kip1).
CONCLUSIONS: In PC3 and DU145 cells, Skp2 is the main determinant in the PI3K/Akt-dependent regulation of p27(kip1). In LNCaP and PC346 cells, PI3K/Akt signaling is not a major factor in p27(kip1) regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425184     DOI: 10.1002/pros.20398

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.

Authors:  J Wu; S-W Lee; X Zhang; F Han; S-Y Kwan; X Yuan; W-L Yang; Y S Jeong; A H Rezaeian; Y Gao; Y-X Zeng; H-K Lin
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

2.  Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.

Authors:  Dong Xiao; Shivendra Vikram Singh
Journal:  Pharm Res       Date:  2010-02-25       Impact factor: 4.200

Review 3.  Skp2: a novel potential therapeutic target for prostate cancer.

Authors:  Zhiwei Wang; Daming Gao; Hidefumi Fukushima; Hiroyuki Inuzuka; Pengda Liu; Lixin Wan; Fazlul H Sarkar; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2011-09-22

4.  Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.

Authors:  Dana-Lynn T Koomoa; Lisette P Yco; Tamas Borsics; Christopher J Wallick; André S Bachmann
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

5.  Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.

Authors:  Daming Gao; Hiroyuki Inuzuka; Alan Tseng; Rebecca Y Chin; Alex Toker; Wenyi Wei
Journal:  Nat Cell Biol       Date:  2009-03-08       Impact factor: 28.824

6.  Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells.

Authors:  Elizabeth Rico-Bautista; Chih-Cheng Yang; Lifang Lu; Gregory P Roth; Dieter A Wolf
Journal:  BMC Biol       Date:  2010-12-23       Impact factor: 7.431

7.  Skp2 is a promising therapeutic target in breast cancer.

Authors:  Zhiwei Wang; Hidefumi Fukushima; Hiroyuki Inuzuka; Lixin Wan; Pengda Liu; Daming Gao; Fazlul H Sarkar; Wenyi Wei
Journal:  Front Oncol       Date:  2012-01-04       Impact factor: 6.244

8.  Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1.

Authors:  Daming Gao; Hiroyuki Inuzuka; Alan Tseng; Wenyi Wei
Journal:  Cell Div       Date:  2009-06-23       Impact factor: 5.130

9.  Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues.

Authors:  Daniel A Smith; Atsushi Kiba; Yang Zong; Owen N Witte
Journal:  Mol Cancer Res       Date:  2013-07-18       Impact factor: 5.852

10.  Phosphoinositide-3-kinases p110α and p110β mediate S phase entry in astroglial cells in the marginal zone of rat neocortex.

Authors:  Rabea Müller; Catharina Fischer; Thomas Wilmes; Bernd Heimrich; Vanessa Distel; Norbert Klugbauer; Dieter K Meyer
Journal:  Front Cell Neurosci       Date:  2013-03-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.